Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) agreed to acquire 51% stake in Ningxia Delixin Medicine Co., Ltd. from Duan Junzhang, Duan Xisheng and Zhao Xupeng for approximately CNY 140 million on July 20, 2022. Ningxia Delixin Medicine Co., Ltd generated the Total Assets of CNY 166.235 million and Net Assets of CNY 31.2436 million for June 2022. Transaction is approved by Board of directors of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd.